These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33804961)

  • 1. Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer.
    Nguyen-Dumont T; Dowty JG; MacInnis RJ; Steen JA; Riaz M; Dugué PA; Renault AL; Hammet F; Mahmoodi M; Theys D; Tsimiklis H; Severi G; Bolton D; Lacaze P; Sebra R; Schadt E; McNeil J; Giles GG; Milne RL; Southey MC
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare germline genetic variants and risk of aggressive prostate cancer.
    Nguyen-Dumont T; MacInnis RJ; Steen JA; Theys D; Tsimiklis H; Hammet F; Mahmoodi M; Pope BJ; Park DJ; Mahmood K; Severi G; Bolton D; Milne RL; Giles GG; Southey MC
    Int J Cancer; 2020 Oct; 147(8):2142-2149. PubMed ID: 32338768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
    Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
    Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
    Karlsson Q; Brook MN; Dadaev T; Wakerell S; Saunders EJ; Muir K; Neal DE; Giles GG; MacInnis RJ; Thibodeau SN; McDonnell SK; Cannon-Albright L; Teixeira MR; Paulo P; Cardoso M; Huff C; Li D; Yao Y; Scheet P; Permuth JB; Stanford JL; Dai JY; Ostrander EA; Cussenot O; Cancel-Tassin G; Hoegel J; Herkommer K; Schleutker J; Tammela TLJ; Rathinakannan V; Sipeky C; Wiklund F; Grönberg H; Aly M; Isaacs WB; Dickinson JL; FitzGerald LM; Chua MLK; Nguyen-Dumont T; ; Schaid DJ; Southey MC; Eeles RA; Kote-Jarai Z
    Eur Urol Oncol; 2021 Aug; 4(4):570-579. PubMed ID: 33436325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.
    Mondschein R; Bolton D; Clouston D; Dowty J; Kavanagh L; Murphy D; Scott P; Taylor RA; Thorne H
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892882
    [No Abstract]   [Full Text] [Related]  

  • 6. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
    Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry.
    Matejcic M; Patel Y; Lilyquist J; Hu C; Lee KY; Gnanaolivu RD; Hart SN; Polley EC; Yadav S; Boddicker NJ; Samara R; Xia L; Sheng X; Lubmawa A; Kiddu V; Masaba B; Namuguzi D; Mutema G; Job K; Henry DM; Ingles SA; Wilkens L; Le Marchand L; Watya S; Couch FJ; Conti DV; Haiman CA
    JCO Precis Oncol; 2020; 4():32-43. PubMed ID: 32832836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer.
    Gheybi K; Jiang J; Mutambirwa SBA; Soh PXY; Kote-Jarai Z; Jaratlerdsiri W; Eeles RA; Bornman MSR; Hayes VM
    J Natl Compr Canc Netw; 2023 Mar; 21(3):289-296.e3. PubMed ID: 36898365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer.
    Rantapero T; Wahlfors T; Kähler A; Hultman C; Lindberg J; Tammela TL; Nykter M; Schleutker J; Wiklund F
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.
    Bancroft EK; Raghallaigh HN; Page EC; Eeles RA
    Curr Genet Med Rep; 2021; 9(4):47-58. PubMed ID: 34790437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.
    Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN
    Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Clinical and Genetic Analysis of
    Kirchner K; Gamulin M; Kulis T; Sievers B; Kastelan Z; Lessel D
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
    Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
    Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer.
    Hirasawa A; Imoto I; Naruto T; Akahane T; Yamagami W; Nomura H; Masuda K; Susumu N; Tsuda H; Aoki D
    Oncotarget; 2017 Dec; 8(68):112258-112267. PubMed ID: 29348823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
    Kote-Jarai Z; Leongamornlert D; Saunders E; Tymrakiewicz M; Castro E; Mahmud N; Guy M; Edwards S; O'Brien L; Sawyer E; Hall A; Wilkinson R; Dadaev T; Goh C; Easton D; ; Goldgar D; Eeles R
    Br J Cancer; 2011 Oct; 105(8):1230-4. PubMed ID: 21952622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing.
    Southey MC; Dowty JG; Riaz M; Steen JA; Renault AL; Tucker K; Kirk J; James P; Winship I; Pachter N; Poplawski N; Grist S; Park DJ; Pope BJ; Mahmood K; Hammet F; Mahmoodi M; Tsimiklis H; Theys D; Rewse A; Willis A; Morrow A; Speechly C; Harris R; Sebra R; Schadt E; Lacaze P; McNeil JJ; Giles GG; Milne RL; Hopper JL; Nguyen-Dumont T
    NPJ Breast Cancer; 2021 Dec; 7(1):153. PubMed ID: 34887416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
    Bancroft EK; Page EC; Brook MN; Pope J; Thomas S; Myhill K; Helfand BT; Talaty P; Ong KR; Douglas E; Cook J; Rosario DJ; Salinas M; Buys SS; Anson J; Davidson R; Longmuir M; Side L; Eccles DM; Tischkowitz M; Taylor A; Cruellas M; Ballestero EP; Cleaver R; Varughese M; Barwell J; LeButt M; Greenhalgh L; Hart R; Azzabi A; Jobson I; Cogley L; Evans DG; Rothwell J; Taylor N; Hogben M; Saya S; ; Eeles RA; Aaronson NK
    BJU Int; 2024 Jun; ():. PubMed ID: 38839570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
    Mijuskovic M; Saunders EJ; Leongamornlert DA; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Govindasami K; Brook MN; Haiman CA; Conti DV; Eeles RA; Kote-Jarai Z
    Br J Cancer; 2018 Jul; 119(1):96-104. PubMed ID: 29915322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants.
    Foley GR; Marthick JR; Lucas SE; Raspin K; Banks A; Stanford JL; Ostrander EA; FitzGerald LM; Dickinson JL
    Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.